Final Alert: 16th EORTC NCI AACR Symposium

There are now only three weeks to go to this joint European Organisation for Research and Treatment of Cancer, US National Cancer Institute and American Association for Cancer Research conference.

It offers:

  • First-time public presentations on new cancer drug research and development from experts in Europe, North America, Asia and Australia.
  • Free registration to bona fide media with official press credentials
  • Media centre with free computing, fax, international phone and internet facilities
  • Two news briefings [12.30 hrs CET: Wednesday 29 September & Thursday 30 September]

Topics at the news briefing or to be press-released include:

  • Results from Phase I study of first second-generation antisense cancer drug used in patients
  • Trial shows which brain cancer patients benefit from temozolomide genetic predictive test clears way to targeted treatment
  • New study indicates arsenic could be suitable first-line treatment for a type of leukaemia
  • Prize-winning study shows Glivec effective in yet another type of cancer
  • A revolutionary approach to anti-angiogenesis researchers find way to exploit tumour blood vessels
  • New cell death-inducing monoclonal antibody results from early study targeting TRAIL R2 protein
  • Lypcopene and vitamin E inhibits prostate tumours new laboratory results underpin epidemiological evidence patient trial now started
  • International trial finds acne-type side effect predicts effectiveness of new targeted treatment
  • Laboratory tests show gossypol abandoned as a contraceptive can sensitise prostate cancer to radiotherapy patient trials now planned

Please note: information above on news briefing & press release topics is for information only and is embargoed until the time of the news briefings or press releases.

The conference is an opportunity for the media to listen and talk to some of the 2,000 European, A

Contact: Margaret Willson
European Organisation for Research and Treatment of Cancer

Page: 1 2

Related biology news :

1. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
2. Final of the 2003/04 Research Councils Business Plan Competition
3. Final results of the two Zevalin pivotal trials in radioimmunotherapy for B cell Non-Hodgkins Lymphoma announced by IDEC Pharmaceuticals
4. L.A.Times Book Prize Finalist: Book On Evolution Of Bird Flight
5. Could A Nasal Vaccine Finally Get Rid Of The Black Death?
6. Last Comment Sought On Agents Proposed For Report On Carcinogens; A Final ForData On Saccharin, And A Re-Review Of Dioxin Announced
7. USGS Issues Wildlife Health Alert: Associates Virus With Salamander Die-Offs
8. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
9. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10. 16th EORTC NCI AACR Symposium
11. Clock cells, tumor suicide, tailored therapies among subjects of AACR-NCI-EORTC Conference

Post Your Comments:

(Date:2/6/2020)... ... February 06, 2020 , ... ... organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, announced ... Strategy. In this newly established role, Dorothy oversees the development and execution ...
(Date:2/1/2020)... ... February 01, 2020 , ... Liver cancer, called hepatocellular ... about 700,000 die from the disease. HCC is the 5th most common cancer and ... all countries when it comes to incidence of HCC, while China has half of ...
(Date:1/29/2020)... WOODLANDS, Texas (PRWEB) , ... January 29, 2020 ... ... grade DNA plasmid, announced it will start production of a DNA vaccine against ... agreement executed with Inovio Pharmaceuticals. A grant of up to $9 million from ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... Intech ... launch of a new and unified global brand identity, as it celebrates its ... engineering challenges, as well as an enthusiasm for designing and manufacturing state-of-the-art medical ...
(Date:2/10/2020)... ... , ... R3 Medical Training announced it is now registering for its next ... course is hands on involving real patients and stem cell biologics, with every attendee ... Cell Training Course has received rave reviews from attendees, who love the hands on ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle ... to food and beverage manufactures within North America. Both Lifecycle and Midland have ... will allow each company to pool their collective resources and provide the industry ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
Breaking Biology Technology:
Cached News: